62 results on '"Block, Timothy"'
Search Results
2. Host RNA quality control as a hepatitis B antiviral target
3. A global scientific strategy to cure hepatitis B
4. Host functions used by hepatitis B virus to complete its life cycle: Implications for developing host-targeting agents to treat chronic hepatitis B
5. Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo
6. Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop
7. HBsAg mRNA degradation induced by a dihydroquinolizinone compound depends on the HBV posttranscriptional regulatory element
8. Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation
9. Novel substituted aminothiazoles as potent and selective anti-hepatocellular carcinoma agents
10. A historical perspective on the discovery and elucidation of the hepatitis B virus
11. The Covalently Closed Circular Form of Hepatitis B Virus Genome: Is There Now an End in “Site”?
12. Chronic hepatitis B: A wave of new therapies on the horizon
13. An interferon-beta promoter reporter assay for high throughput identification of compounds against multiple RNA viruses
14. Antiviral therapies targeting host ER alpha-glucosidases: Current status and future directions
15. Design and synthesis of N-alkyldeoxynojirimycin derivatives with improved metabolic stability as inhibitors of BVDV and Tacaribe virus
16. Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses
17. Sa1269 Serum Anti-Gal Levels in Celiac Disease Patients
18. N-Alkyldeoxynojirimycin derivatives with novel terminal tertiary amide substitution for treatment of bovine viral diarrhea virus (BVDV), Dengue, and Tacaribe virus infections
19. Chronic hepatitis B: What should be the goal for new therapies?
20. Screening and identification of compounds with antiviral activity against hepatitis B virus using a safe compound library and novel real-time immune-absorbance PCR-based high throughput system
21. The innate immune response to hepatitis B virus infection: Implications for pathogenesis and therapy
22. Su1933 Correlation of a Sub Set of Serum Anti-Gal Levels With Disease Phenotype in Patients With Active Crohn's Disease
23. Quantitative dynamics of hepatitis B basal core promoter and precore mutants before and after HBeAg seroconversion
24. Detection of Hypermethylated Vimentin in Urine of Patients with Colorectal Cancer
25. Competitive inhibitor of cellular α-glucosidases protects mice from lethal dengue virus infection
26. Development of recombinant Aleuria aurantia lectins with altered binding specificities to fucosylated glycans
27. A Locked Nucleic Acid Clamp-Mediated PCR Assay for Detection of a p53 Codon 249 Hotspot Mutation in Urine
28. Quantification of complex precore mutations of hepatitis B virus by SimpleProbe real time PCR and dual melting analysis
29. Combination of α-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo
30. Synthesis and Biological Evaluation of Triazolo-pyrimidine Derivatives as Novel Inhibitors of Hepatitis B Virus Surface Antigen (HBsAg) Secretion
31. Novel Imino Sugars Potently Inhibit HCV Virion Secretion by Targeting Cellular Endoplasmic Reticulum α-Glucosidases
32. Antiviral activity of geneticin against dengue virus
33. Antiviral effect of interferon lambda against West Nile virus
34. Rapid and sensitive detection of hepatitis B virus 1762T/1764A double mutation from hepatocellular carcinomas using LNA-mediated PCR clamping and hybridization probes
35. A Tetrazolo-pyrimidine Induces Intracellular Redistribution of Hepatitis B Surface Antigen, Resulting in Reduced Secretion
36. Novel Imino Sugar Derivatives Demonstrate Potent Antiviral Activity against Dengue Virus
37. Inhibition of Hepatitis B Virus Replication by a Set of Small Interferon-stimulated Genes
38. Inhibition of cellular alpha-glucosidases results in increased presentation of hepatitis B virus glycoprotein-derived peptides by MHC class I
39. Human Immunodeficiency Virus-Related Microbial Translocation and Progression of Hepatitis C
40. A Novel and Selective Inhibitor of Hepatitis B Virus Surface Antigen Secretion
41. Novel Five-membered Ring Imino Sugar Derivatives Inhibit Flaviviruses via Distinct Mechanisms
42. The degradation pathway for the HBV envelope proteins involves proteolysis prior to degradation via the cytosolic proteasome
43. Molecular Virology of Hepatitis B Virus for Clinicians
44. The role of the downstream signal sequences in the maturation of the HBV middle surface glycoprotein: Development of a novel therapeutic vaccine candidate
45. Hepatitis B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral screening assays
46. Lectin Capture Strategies Combined with Mass Spectrometry for the Discovery of Serum Glycoprotein Biomarkers
47. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma
48. Assays for glucosidase inhibitors with potential antiviral activities: secreted alkaline phosphatase as a surrogate marker
49. A phage with high affinity for hepatitis B surface antigen for the detection of HBsAg
50. Human Urine Contains Small, 150 to 250 Nucleotide-Sized, Soluble DNA Derived from the Circulation and May Be Useful in the Detection of Colorectal Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.